Kazia Therapeutics (KZIA) Income from Non-Controlling Interests (2009 - 2012)

Kazia Therapeutics (KZIA) has 4 years of Income from Non-Controlling Interests data on file, last reported at $1.7 million in Q2 2012.

• In Q2 2012, Income from Non-Controlling Interests rose 716.27% year-over-year to $1.7 million; the TTM figure through Jun 2012 stood at $1.7 million (up 716.27% YoY), while the FY2016 annual figure was -$67049.3, changed N/A from the prior year.
• Income from Non-Controlling Interests advanced to $1.7 million in Q2 2012, from $202781.6 in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at $3.9 million in Q2 2009 and bottomed at $202781.6 in Q2 2011.
• A 4-year average of $1.9 million and a median of $1.7 million in 2012 frame the typical range for Income from Non-Controlling Interests.
• Annual changes were most pronounced in 2011 — Income from Non-Controlling Interests tumbled 88.46% — and 2012, when it soared 716.27%.
• Year by year, Income from Non-Controlling Interests stood at $3.9 million in 2009, then tumbled by 54.56% to $1.8 million in 2010, then tumbled by 88.46% to $202781.6 in 2011, then jumped by 716.27% to $1.7 million in 2012.
• The last three Income from Non-Controlling Interests figures came in at $1.7 million (Q2 2012), $202781.6 (Q2 2011), and $1.8 million (Q2 2010), per Business Quant data.

Peer Comparison